ASPCP News

For hospice, hospital, community, clinical commissioning groups, research & academic pharmacists working in or with palliative care.

Hold the date! ASPCP Annual Conference 15th Nov 2018

Returning back to Birmingham in 2018 we are delighted to announce the date of our annual ASPCP conference. Tickets go on sale on 1st March when you can benefit from our early bird rate up until the 1st August. We are still confirming the programme but the following...

ASPCP SOUTH EAST GROUP MEETING

Reminder to all members in the south east our local meeting is on THURSDAY 18TH JANUARY.  We have booked a room at Hospice House Britannia Street Kings Cross from 1pm.  Tea and coffee provided - bring lunch with you. Please send any agenda items to Margaret Gibbs...

Onexila

Legal Class: POM Schedule 2 Controlled Drug Drug Class: Opioid analgesic Active Ingredient: oxycodone hydrochloride Onexila XL 10mg prolonged release tablets x28 = £12.52 Onexila XL 20mg prolonged release tablets x28 = £12.52 Onexila XL 40mg prolonged...

End of Life Care Course for Pharmacists

A one day course on end of life care at the Sobell study centre in Oxford for practising pharmacists from hospital, community, hospice or GP practices. The course covers a variety of topics including managing symptoms at the end of life, deprescribing, syringe...

AGM reports

We are counting down to our 10th AGM which will be held during our annual conference on 16th November 2017. To ensure the smooth running of the meeting all papers and reports will be made available on the website in advance. The financial summary and draft...

New ASPCP Constitution

We would like to consult with all members on our updated ASPCP Constitution. The Constitution can only be changed at the AGM if two thirds of members agree to the change however we invite comments in advance from all members including those not attending the AGM....

Pregabalin guidance in drug misuse

This guidance sets out how to reduce the risks for people using pregabalin. Though not specifically palliative care it makes an interesting read considering the increase in use and abuse of this drug. You may find the information on tolerance and withdrawal helpful...